Client Login
Pay My Bill
Services
Adherence Monitoring
Pain Management
Mental Illness
Substance Use Disorder
Chronic Comorbidities
BioDetect
Novel Psychoactive Substances
2023 NPS Summary
InterACT Rx
Sports Testing
Clinical Blood Testing
Infectious Disease Testing
Clinical Resources
About Definitive Testing
Clinical Updates
Webinars
Events
Patient Impact Stories
Publications
Reference Guide
Collection Instructions
Work With Us
Current Openings
About
The Aegis Difference
Executive Leadership
Clinical and Scientific Team
Testimonials
Lab Tour
News
Contact
Client Login
Pay My Bill
Services
Adherence Monitoring
Pain Management
Mental Illness
Substance Use Disorder
Chronic Comorbidities
BioDetect
Novel Psychoactive Substances
2023 NPS Summary
InterACT Rx
Sports Testing
Clinical Blood Testing
Infectious Disease Testing
Clinical Resources
About Definitive Testing
Clinical Updates
Webinars
Events
Patient Impact Stories
Publications
Reference Guide
Collection Instructions
Work With Us
Current Openings
About
The Aegis Difference
Executive Leadership
Clinical and Scientific Team
Testimonials
Lab Tour
News
Contact
Client Login
Pay My Bill
Publications
Studies, White Papers, and Conferences
Studies & Findings
View studies and summary reports.
Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
National Surveillence of COVID-19 Infections:Variants, Vaccination Status, and Viral Spread
Scaling a High Throughput Next Generation Sequencing Laboratory for Community Surveillance of Sars-Cov-2 Viral Variants During the Public Health Crisis
Estimated BNT162b2 Vaccine Effectiveness Against Infection with Delta and Omicron Variants Among US Children 5 to 11 Years of Age
Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens
Evaluation of an Optimized Protocol and Illumina ARTIC V4 Primer Pool for Sequencing of SARS-CoV-2 Using COVIDSeq™ and DRAGEN™ COVID LineageApp Workflow
Top Rated Abstract When Reviewed by the ACMG Annual Clinical Genetics Meeting Program Committee: Tracking the Emergence of Sars-Cov-2 Variants of Concern in Vaccinated and Unvaccinated Patients
Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variants
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
White Papers
Learn more by clicking the links below.
Synthetic Substitution: Identifying Non-Urine Substances Amidst Medication Compliance Testing
Next Generation Sequencing: Monitoring Change during the COVID-19 Pandemic
Capturing the Truth – Quality-Driven Laboratory Results to Improve Patient Outcomes
Assisting a Community at a Crossroads: Tools to Support the Fight in the Ongoing Opioid Epidemic
Scientific Research
View Poster Presentations.
Buprenorphine Co-positivity with Designer Benzodiazepines in Routine Healthcare Urine Samples
Designer Benzodiazepine Positivity and Co-Positivity in Urine Specimens Received December 2020 to April 2021
Scaling a High Throughput Next Generation Sequencing Laboratory for Community Surveillance of Sars-Cov-2 Viral Variants During the Public Health Crisis
Oral Fluid as a Viable Matrix for Detecting Drug-Drug Interactions
Detection of Eutylone in Chronic Pain and Behavioral Health Populations
Sign up for the Aegis Newsletter
Δ
Close